Ovarian Cancer Virtual Education Series
In collaboration with expert clinicians, The European Society of Pathology (ESP), the Association for Molecular Pathology (AMP), AstraZeneca, & MSD have developed educational modules on diagnostic testing in ovarian cancer patients. This Virtual Education Series consists of key modules designed to provide training on the theoretical, technical, and practical aspects of diagnostic testing in ovarian cancer, as well as supporting videos and a self-assessment to ensure the principles and need for diagnostic testing are understood.
This six-part series consists of key modules designed to provide training on the theoretical, technical, and practical aspects of diagnostic testing in ovarian cancer. Modules can be completed in any order.
Each Module Contains
- Pre-module assessment
- Webinar Recording
- Module evaluation
- Post-module assessment
- Downloadable handout
Once you complete the pre-module assessment the video will be accessible to view on the page.
Modules
Ovarian cancer, pathology and homologous recombination deficiency
Speaker: Xavier Matias-Guiu
Somatic BRCA mutation testing in ovarian cancer
Speaker: Gerald Hofler
Principles behind homologous recombination
deficiency testing in ovarian cancer
Speaker: Karl Kashofer
Ovarian virtual education platform practical module: germline BRCA
testing
Speaker: Dr. Conxi Lazaro
Best practice for molecular testing in ovarian cancer tissue samples
Speakers: Sven Perner, MD, PhD, FRCPath and Clara Luehr, MD
Novel approaches to genomic instability testing in ovarian cancer patients
Speaker: Frédérique Penault-Llorca
Target Audience
HCP’s with an interest or role associated with Ovarian Cancer diagnostics.
Modules 1-5 Recorded:
Spring 2021
Module 6 Recorded: Summer 2023
Expire from Catalog:
March 6, 2026
Learners will be awarded a Certificate of Attendance at the conclusion of the course. CME or CMLE credits are NOT available for this educational series.
Speaker: Karl Kashofer
Speaker: Dr. Conxi Lazaro
Speakers: Sven Perner, MD, PhD, FRCPath and Clara Luehr, MD
Module 6 Recorded: Summer 2023
Learners will be awarded a Certificate of Attendance at the conclusion of the course. CME or CMLE credits are NOT available for this educational series.
This educational content was co-developed and funded by AstraZeneca and MSD. The authors, reviewers, and editors of these educational materials have made extensive efforts to ensure that treatments, diagnostics and discussions about medical practice are accurate and conform to the standards accepted at the time of publication. However, constant changes in information resulting from continuing research and clinical experience, reasonable differences in opinions among authorities, unique aspects of individual clinical situations, and the possibility of human error in preparing a series of educational materials mean that other sources of medical information may differ from the information on this site. Content in the educational materials reflects medical practice and information in Europe. Outside of Europe, clinical guidelines, practice standards, and professional opinion may differ and the reader is advised to also consult local medical sources. Z4-47631; Date of preparation: August 2022.
